Suchergebnisse - "Bantilan, Kurt S"

PubPharm (8)

1

Matched control analysis suggests R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared to R-CHOP

enthalten in: Blood advances | 2024

von Bantilan, K. | Smith, A. | Maurer, M. | +15

2

Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia : identifying risk factors to help guide treatment selection

enthalten in: Leukemia & lymphoma | 2023

von Bantilan, K. | Kay, N. | Parikh, S. | +9

3

Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen

enthalten in: Blood advances | 2022

von Thompson, M. | Harrup, R. | Coombs, C. | +35

4

The impact of anti-CD20-based therapy on hypogammaglobulinemia in patients with follicular lymphoma

enthalten in: Leukemia & lymphoma | 2022

von Fischer, T. | Ni, A. | Bantilan, K. | +5

5

Time from diagnosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma

enthalten in: Leukemia & lymphoma | 2020

von Soumerai, J. | Ni, A. | Alperovich, A. | +8

6

Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation

enthalten in: British journal of haematology | 2016

von Shah, G. | Yahalom, J. | Matasar, M. | +7

7

Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation

enthalten in: British journal of haematology | 2016

von Shah, G. | Yahalom, J. | Matasar, M. | +7

8

Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation

enthalten in: British journal of haematology | 2016

von Shah, G. | Yahalom, J. | Matasar, M. | +7

1
[1]